Al-Muhid was appointed Group CEO of SCCH in February 2020. The group has five companies: SITCO Pharma, AJA Pharma, Chemical Company for Commercial Investment Ltd, the Suez International Nitrate Company, and the Saudi Chemical Company Ltd. SCCH recorded revenues of $909.6 million and assets worth $1.23 billion in 2021. In June 2021, the company announced a five-year agreement with GlaxoSmithKline for the AJA Pharma manufacturing site in Saudi Arabia. Al-Muhid previously held roles at SABIC, GE, and Almarai. He is also chairman of the Suez International Nitrate Company and sits on the board for the Southern Province Cement Company.